Back
BeiGene Vs. Theravance Biopharma Industry Stock Comparison
Sell
27
BGNE
BeiGene
Last Price:
156.28
Seasonality Move:
7.7%
Buy
57
TBPH
Theravance Biopharma
Last Price:
8.90
Seasonality Move:
-4.73%
Sell
27
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $154.79. The Score for BGNE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Theravance Biopharma (TBPH)
is a Buy
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $9.01. The Score for TBPH is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- TBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BGNE Stock Price Chart
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $9.01
The current trend is relatively stagnant and TBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
BGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 43.66 | Sell |
Chaikin Money Flow: | 14748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (156.18 - 171.38) | Sell |
Bollinger Bands (100): | (155.51 - 185.95) | Sell |
TBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 52.6 | Buy |
Chaikin Money Flow: | 291852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.6 - 9.22) | Buy |
Bollinger Bands (100): | (8.88 - 10.72) | Sell |
BGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 160.6 | Sell |
20-day SMA: | 163.35 | Sell |
50-day SMA: | 158.29 | Sell |
200-day SMA: | 181.01 | Sell |
8-day EMA: | 158.73 | Sell |
20-day EMA: | 161.13 | Sell |
50-day EMA: | 162.72 | Sell |
200-day EMA: | 180.19 | Sell |
TBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.87 | Buy |
20-day SMA: | 8.84 | Buy |
50-day SMA: | 9.03 | Sell |
200-day SMA: | 9.74 | Sell |
8-day EMA: | 8.87 | Buy |
20-day EMA: | 8.87 | Buy |
50-day EMA: | 9.13 | Sell |
200-day EMA: | 9.73 | Sell |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.91 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $4.91 per share.
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
BeiGene Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theravance Biopharma Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |